Israel’s MyHomeDoc has received US FDA approval to add to its EU and Israeli certifications. The device has 4 embedded sensors to analyze and report lung, heart, and bowel sounds, otoscopy for the ear, oximeter for pulse rate and saturation, … Continue reading →

Israel’s IceCure already has US FDA approval for its cryogenic (freezing) treatment of cancer (reported here previously). The latest FDA Breakthrough Device designation, however, will speed up procedures regarding permits for IceCure’s Prosense device to treat cancer patients. https://www.timesofisrael.com/icecure-shares-up-as-tumor-freezing-tech-gets-fda-breakthrough-device-nod/

Israel’s MyBiotics (see here previously) is to partner Hadasit – the technology transfer arm of Hadassah Medical Center, to identify gut microbiome-based cancer therapies. They will study up to 100 melanoma patients treated with PD-1/PD-L1 checkpoint inhibitor immunotherapies. https://www.timesofisrael.com/mybiotics-hadassah-to-study-impact-of-microbiome-on-cancer-therapies/

Researchers at Tel Aviv University have discovered a potential treatment for the aggressive brain cancer Glioblastoma. Over-secretion of the protein P-Selectin (SELP) boosts tumor growth. Inhibiting SELP slowed growth and stopped cancer cells migrating to the brain. https://www.israel21c.org/cure-for-deadly-brain-cancer-may-be-on-its-way/ https://www.youtube.com/watch?v=qaWYYwbayUI

Researchers at Israel’s Weizmann Institute and the Hebrew University of Jerusalem, with UK colleagues, have found that melanocortin 4 (MC4) receptor is the master switch for hunger in the brain. It is normally “on” (“I feel full”) until energy levels … Continue reading →

Unvaccinated children of Covid-19 vaccinated parents are far less likely to contract the virus. Researchers at Israel’s Technion and health company Maccabi used data from 223 Israeli communities to show each 20% increase in parental vaccination halves the incidence of … Continue reading →